135 related articles for article (PubMed ID: 25490144)
1. Glucose intolerance in aging male IGFBP-3 transgenic mice: differential effects of human IGFBP-3 and its mutant IGFBP-3 devoid of IGF binding ability.
Nguyen KH; Yao XH; Erickson AG; Mishra S; Nyomba BL
Endocrinology; 2015 Feb; 156(2):462-74. PubMed ID: 25490144
[TBL] [Abstract][Full Text] [Related]
2. In vitro differentiation of mouse brown preadipocytes is enhanced by IGFBP-3 expression and reduced by IGFBP-3 silencing.
Nguyen KH; Mishra S; Nyomba BL
Obesity (Silver Spring); 2015 Oct; 23(10):2083-92. PubMed ID: 26333724
[TBL] [Abstract][Full Text] [Related]
3. Human IGF binding protein-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion.
Nguyen KH; Yao XH; Moulik S; Mishra S; Nyomba BL
Endocrinology; 2011 Jun; 152(6):2184-96. PubMed ID: 21447640
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.
Silha JV; Gui Y; Mishra S; Leckstrom A; Cohen P; Murphy LJ
Endocrinology; 2005 Mar; 146(3):1523-31. PubMed ID: 15550509
[TBL] [Abstract][Full Text] [Related]
5. Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice.
Silha JV; Gui Y; Murphy LJ
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E937-45. PubMed ID: 12376320
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
Benbassat CA; Maki KC; Unterman TG
J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.
Silha JV; Sheppard PC; Mishra S; Gui Y; Schwartz J; Dodd JG; Murphy LJ
Endocrinology; 2006 May; 147(5):2112-21. PubMed ID: 16469805
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice.
Modric T; Silha JV; Shi Z; Gui Y; Suwanichkul A; Durham SK; Powell DR; Murphy LJ
Endocrinology; 2001 May; 142(5):1958-67. PubMed ID: 11316761
[TBL] [Abstract][Full Text] [Related]
9. Gender differences in the insulin-like growth factor axis response to a glucose load.
Flanagan DE; Holt RI; Owens PC; Cockington RJ; Moore VM; Robinson JS; Godsland IF; Phillips DI
Acta Physiol (Oxf); 2006 Jul; 187(3):371-8. PubMed ID: 16776662
[TBL] [Abstract][Full Text] [Related]
10. Pappa2 deletion alters IGFBPs but has little effect on glucose disposal or adiposity.
Christians JK; Bath AK; Amiri N
Growth Horm IGF Res; 2015 Oct; 25(5):232-9. PubMed ID: 26164771
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain.
Bienvenu G; Seurin D; Le Bouc Y; Even P; Babajko S; Magnan C
Diabetologia; 2005 Jun; 48(6):1189-97. PubMed ID: 15889232
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.
Hoeflich A; Wu M; Mohan S; Föll J; Wanke R; Froehlich T; Arnold GJ; Lahm H; Kolb HJ; Wolf E
Endocrinology; 1999 Dec; 140(12):5488-96. PubMed ID: 10579311
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
14. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study.
Sandhu MS; Heald AH; Gibson JM; Cruickshank JK; Dunger DB; Wareham NJ
Lancet; 2002 May; 359(9319):1740-5. PubMed ID: 12049864
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
[TBL] [Abstract][Full Text] [Related]
16. The role of insulin-like growth factor (IGF) binding protein-2 in the insulin-mediated decrease in IGF-I bioactivity.
Arafat AM; Weickert MO; Frystyk J; Spranger J; Schöfl C; Möhlig M; Pfeiffer AF
J Clin Endocrinol Metab; 2009 Dec; 94(12):5093-101. PubMed ID: 19846739
[TBL] [Abstract][Full Text] [Related]
17. Diminished growth and enhanced glucose metabolism in triple knockout mice containing mutations of insulin-like growth factor binding protein-3, -4, and -5.
Ning Y; Schuller AG; Bradshaw S; Rotwein P; Ludwig T; Frystyk J; Pintar JE
Mol Endocrinol; 2006 Sep; 20(9):2173-86. PubMed ID: 16675541
[TBL] [Abstract][Full Text] [Related]
18. The insulin-like growth factor axis and plasma lipid levels in the elderly.
Ceda GP; Dall'Aglio E; Magnacavallo A; Vargas N; Fontana V; Maggio M; Valenti G; Lee PD; Hintz RL; Hoffman AR
J Clin Endocrinol Metab; 1998 Feb; 83(2):499-502. PubMed ID: 9467564
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes.
Chan SS; Twigg SM; Firth SM; Baxter RC
J Clin Endocrinol Metab; 2005 Dec; 90(12):6588-95. PubMed ID: 16189260
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age.
de Kort SW; van Doorn J; van de Sande AG; Leunissen RW; Hokken-Koelega AC
J Clin Endocrinol Metab; 2010 Feb; 95(2):864-71. PubMed ID: 20061427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
